Brief: Enorama Pharma Q2 Operating Loss Widens To SEK 4.0 Million
14/08/2019 07:33
Aug 14 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q2 OPERATING LOSS SEK 4.0 MILLION VERSUS LOSS SEK 3.1
MILLION
YEAR AGO
* Q2 NET SALES SEK 4.2 MILLION VERSUS SEK 1.7 MILLION YEAR
AGO
Source text for Eikon: ID:nWkr48TyFs
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO